维普期刊资源整合服务平台（V6.5）

93篇 您的检索式：作者名="Gane N"

选中清除导出查看参考文献查看引证文献引用追踪共5页首页上一页第1页下一页末页 /5 跳转

	题名	作者	年代	出处	被引量
1	2-Year GLOBE trial results:telbivudine is superior to lamivudine in patients with chronic hepatitis B显示文摘	Liaw YF Gane E Leung N		Gastroenterology0，，：	2
2	2-Year GLOBE trial results:telbivudine Is superior to lamivudine in patients with chronic hepatitis B显示文摘	Liaw YF Gane E Leung N	2009	Gastroenterology2009，136，2：	1
3	2 - Year GLOBE trial resuits: telbivudine Is superior to lamivudine in patients with chronic hepatitis B 显示文摘	Liaw YF Gane E Leung N	2009	Gastroenterology2009，136，2：	1
4	2 -Year GLOBE trial results: telbivudine is superior to lamivudine in patients with chronic hepatitis B 显示文摘	LIAW YF GANE E LEUNG N	2009	Gastroenterology2009，136，2：	1
5	2-year GLOBE trial results:Teibivudine is superior to lamivudine inpatients with chronic hepatitis B显示文摘	LIAW YF GANE E LEUAG N	2009	Gastroenterology2009，136，：	1
6	2 -Year GLOBE trial results: telbivudine is superior to lamivudine in patients with chronic hepatitis B 显示文摘	Liaw YF Gane E Leung N	2009	Gastroenterology2009，136，2：	1
7	AQP3 deficiency in humans and the molecular basis of a novel blood group system, GIL 显示文摘	Roudier N Ripoche P Gane P	2002	J Biol Chem2002，277，45：	1
8	2-year GLOBE trial re- suits: telbivudine is superior to lamivudine in patients with chronic hepatitis B 显示文摘	Liaw YF Gane E Leung N	2009	Gastroenterology2009，136，2：	1
9	Oral combination therapy with a nucleoside polymerase inhibitor (RG7128) and danoprevir for chronic hepatitis C genotype 1 infection (INFORM-1): a randomised, double-blind, placebo-controlled, dose-escalation trial显示文摘	Edward J Gane Stuart K Roberts Catherine AM Stedman Peter W Angus Brett Ritchie Rob Elston David Ipe Peter N Morcos Linda Baher Isabel Najera Tom Chu Uri Lopatin M Michelle Berrey William Bradford Mark Laughlin Nancy S Shulman Patrick F Smith	2010	The Lancet2010，，9751：	1
10	Seven years of treatment with tenofovir DF for chronic hepatitis B virus infection is safe and well tolerated and associated with sustained virological,biochemical and serological response with no detectable resistance显示文摘	Marcellin P Gane EJ Tsai N	2013	Hepatology2013，58，1：	1
11	2 - Year GLOBE trial re- sults:telbivudine is superior to lamivudine in patients with chronic hepatitisB 显示文摘	Liaw YF Gane E Leung N	2009	Gastroenterology2009，，2：	1
12	2-Year GLOBE trial results:telbivudine is superior to lamivudine in patients with chronic hepatitis B显示文摘	Liaw YF Gane E Leung N	2009	Gastroenterology2009，136，2：	1
13	2- Year GLOBE trial results: telbivudine is superior to lamivudine in patients with chronic hepatitis B显示文摘	Liaw YF Gane E Leung N	2009	Gastroenterology2009，136，：	1
14	Seven years of treatment with tenofovir DF for chronic hepatitis B virus infection is safe and well tolerated and associated with sustained virological, biochemical and serological responses with no detectable resistance显示文摘	Marcellin P Gane EJ Tsai N	2013	Hepatology2013，，：	1
15	Structural characteriza- tion of plasma sprayed hydroxyapatite coatings 显示文摘	Mcpherson R Gane N Bastow T	1995	Journal of Materials Science-Materials in Medicine1995，6，6：	1
16	AQP3 deficiency in human and the molecular basis of a novel blood group system,GIL显示文摘	Roudier N Ripoche P Gane P	2002	J Biol Chem2002，277，45：	1
17	2-Year GLOBE trial results:telbivudine is superior to lamivudine in patients with chronic hepatitis B显示文摘	Liaw YF Gane E Leung N	2009	Gastroenterology2009，136，：	1
18	2-Year GLOBE trial results:telbivudine is superior to lamivudine in patients with chronic hepatitis B显示文摘	Liaw YF Gane E Leung N	2009	Gastroenterology2009，136，2：	1
19	2-year GLOBE trial results: telbivudine is superior to lamivudine in patients with ehronie hepa- titis B显示文摘	Liaw YE Gane E Leung N	2009	Gastroenterology2009，136，2：	1
20	2-Year GLOBE trial resuts:telbivudine Is superior to Lamivudine in patients with chronic heptistis显示文摘	LIAW YF GANE E LENG N	2009	Gastroenterology2009，136，2：	1

返回顶部每页显示：

共5页首页上一页第1页下一页末页 /5 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示